Retifanlimab
Drug timelines are a Plus or Pro feature.
24 regulatory and trial events tracked for Retifanlimab, covering 2023-12-20 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO) [Phase 2]